Neuspera Medical Raises $23 Million in Series D Financing led by Vertex Ventures HC and Treo Ventures
Amount Raised
$23 Million
Round Type
Series D
SunnyvaleBiotechnologyHealthcareInvestors
Description
Neuspera Medical, Inc., a neuromodulation company, has closed its Series D funding round, raising $23 million. The round was led by Vertex Ventures HC and Treo Ventures, with participation from Action Potential Venture Capital, Windham Venture Partners, Olympus Innovation Ventures, and another strategic investor. The funding will support the expected U.S. Food and Drug Administration (FDA) premarket approval (PMA) of the Neuspera System, designed to provide relief from urinary urge incontinence (UUI), a symptom of overactive bladder (OAB).
Quick answer
NeuSpera Medical raised $23 Million in a Series D round, dated July 15, 2024. Investors: Olympus Innovation Ventures, Windham Venture Partners, Action Potential Venture Capital, Treo Ventures and Vertex Ventures HC. NeuSpera Medical is based in Sunnyvale, California, United States.
- How much did NeuSpera Medical raise?
- NeuSpera Medical raised $23 Million in a Series D round on July 15, 2024.
- Who invested in NeuSpera Medical?
- Olympus Innovation Ventures, Windham Venture Partners, Action Potential Venture Capital, Treo Ventures and Vertex Ventures HC are named as investors in this round.
- What does NeuSpera Medical do?
- Neuspera Medical, Inc. is committed to developing implantable medical devices that will improve the lives of patients battling chronic illnesses.
- Where is NeuSpera Medical based and how big is it?
- NeuSpera Medical is based in Sunnyvale, California, United States.
- Who are the decision-makers at NeuSpera Medical?
- Fundz holds 2 contacts at NeuSpera Medical, including the Executive Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Biotechnology around the same time
Companies in the same sectors as NeuSpera Medical that raised within 45 days of this round, from Fundz verified event records.
- Ensysce Biosciences raised $5.1M on August 29, 2024.
- Zyppah raised $60K (Pre-Seed) on August 26, 2024.
- Endovia Health Sciences, Inc. raised $600K (Seed) on August 22, 2024.
- Bond Biosciences raised $2.6M (Seed) on August 22, 2024.
- Retension Pharmaceuticals raised $10M (Series A) on August 21, 2024.
- Pharmazz raised $7.5M on August 15, 2024.
Who to call at NeuSpera Medical, and when
A new round usually means NeuSpera Medical is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day NeuSpera Medical raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at NeuSpera Medical, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at NeuSpera Medical. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment NeuSpera Medical raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
NeuSpera Medical raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.